Latest Insights on CLOU
The Wrong Reason To Sell Tesla October 3, 2022 Great Stuff
The Wrong Reason To Sell Tesla Great Ones, by now I’m sure you’re all aware of my mixed feelings about Tesla (Nasdaq: ). I’m all for green energy, electric vehicles (EVs), improving battery technology and all that jazz. At one point, I was even planning on making a Tesla my next car purchase. Those Model […]
Micron’s Unbearable Earnings, Pay-To-Play FDA & Peloton Needs Dick’s September 30, 2022 Great Stuff
Friday Four Play: The “Bearish Exhaustion?” Edition Great Ones, I don’t like to give y’all false hope, but Micron Technology (Nasdaq: ) just continued a trend I’ve noticed building on Wall Street lately. That trend? A company issues pretty bad news, but the stock rallies anyway. In the sentiment analysis business, we call this an […]
Apple’s Appealing Advantage, Not So RAD & Beyond’s Crazy September 29, 2022 Great Stuff
These Apples Are Delicious? As a matter of fact, they are, Great Ones. Can all this fruit be free? Unfortunately, no. Apple (Nasdaq: ) is not free. But AAPL stock is down about 20% so far this year, so we’ve got that going for us … which is nice? Well, for bargain hunters at least. […]
SaaS: The #1 Growing Tech for Modern Businesses September 29, 2022 Investment Opportunities, Technology, Trending, Winning Investor Daily
Netflix, Spotify and Slack are using SaaS: a tech that could become a $537 billion market. Amber reveals her top SaaS stock pick for 2022!
Biogen’s Alzheimer’s All-Timer, Thor Thunders On, Cowardly Lionsgate September 28, 2022 Great Stuff
Biogen’s Redemption Song Great Ones, so this ain’t the end, I saw Biogen (Nasdaq: ). Today, I had to turn my heart away. The news smelled like the sun, BIIB for everyone. And tales … it never fails. I’ve been lying so low in the weeds that Biogen’s latest Alzheimer’s drug ambushed me. It’s got […]






